SEM
SELECT MEDICAL HOLDINGS CORPMarquee-fund ownership over time
This quarter's activity
New positions opened
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors re-entered | Q3 2024(8Q snapshot) | 7Q | $17 | $16 | -2% |
| Two Sigma Investments re-entered | Q3 2024(8Q snapshot) | 7Q | $17 | $16 | -2% |
| D.E. Shaw | Q3 2024(8Q snapshot) | 7Q | $17 | $16 | -2% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $17 | $16 | -2% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $17 | $16 | -2% |
| Soros Fund Management | Q2 2026(8Q snapshot) | 1Q | $17 | $16 | -0% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates | Q4 2025 | Q2 2026 | → $17 | +25% |
| Point72 Asset Management | Q3 2024 | Q1 2026 | → $16 | -3% |
| Renaissance Technologies | Q4 2024 | Q4 2025 | → $13 | -34% |
| Maverick Capital | Q2 2018 | Q3 2018 | → $9.65 | +7% |
| JANA Partners | Q4 2016 | Q1 2018 | → $8.15 | +34% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at SELECT MEDICAL HOLDINGS CORP. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from May 5, 2026 — the most recent Form 4 on file — not from today.
- Form 40001472553-26-000002May 5, 2026
- Form 40001169897-26-000002May 1, 2026
- Form 40001477553-26-000004Apr 29, 2026
- Form 40001477553-26-000002Feb 13, 2026
- Form 40002081450-25-000004Nov 4, 2025
- Form 40001966990-25-000004Nov 4, 2025
- Form 40002081450-25-000002Oct 30, 2025
- Form 40001477553-25-000004Oct 30, 2025
- Form 40001966947-25-000004Oct 30, 2025
- Form 40001415889-25-020958Aug 4, 2025
- Form 40001415889-25-020956Aug 4, 2025
- Form 40001415889-25-020954Aug 4, 2025
- Form 40001415889-25-020952Aug 4, 2025
- Form 40001415889-25-020950Aug 4, 2025
- Form 40001415889-25-020940Aug 4, 2025
Fundamentals
XBRL · SELECT MEDICAL HOLDINGS CORPAnnual figures sourced directly from SELECT MEDICAL HOLDINGS CORP's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for SELECT MEDICAL HOLDINGS CORP — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KFORM 8-KApr 30, 2026
- 10-QQuarterly reportApr 30, 2026
- 8-KFORM 8-KApr 24, 2026
- DEF 14AFORM-DEF 14AMar 4, 2026
- 8-KFORM 8-KMar 3, 2026
- 10-KAnnual reportFeb 19, 2026
- 8-KFORM 8-KFeb 19, 2026
- 8-KFORM 8-KDec 19, 2025
- 8-KFORM 8-KNov 25, 2025
- 8-KFORM 8-KOct 30, 2025
- 10-QQuarterly reportOct 30, 2025
- 8-KFORM 8-KSep 2, 2025
- 8-KFORM 8-KAug 4, 2025
- 8-KFORM 8-KJul 31, 2025
- 10-QQuarterly reportJul 31, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Soros Fund Management | Q2 2026 | open | $17 | $16 | -0% |
| Two Sigma Investments | Q4 2025 | open | $13 | $16 | +27% |
| Bridgewater Associates | Q4 2025 | Q2 2026 | $13 | $17 | +25% |
| Citadel Advisors | Q3 2025 | open | $12 | $16 | +32% |
| Two Sigma Investments | Q2 2025 | Q3 2025 | $15 | $12 | -17% |
| Citadel Advisors | Q1 2025 | Q2 2025 | $18 | $15 | -18% |
| Renaissance Technologies | Q4 2024 | Q4 2025 | $20 | $13 | -34% |
| Citadel Advisors | Q3 2024 | Q4 2024 | $17 | $20 | +17% |
| Two Sigma Investments | Q3 2024 | Q1 2025 | $17 | $18 | +9% |
| D.E. Shaw | Q3 2024 | open | $17 | $16 | -2% |
| AQR Capital Management | Q3 2024 | open | $17 | $16 | -2% |
| Millennium Management | Q3 2024 | open | $17 | $16 | -2% |
| Point72 Asset Management | Q3 2024 | Q1 2026 | $17 | $16 | -3% |
| Maverick Capital | Q2 2018 | Q3 2018 | $8.98 | $9.65 | +7% |
| JANA Partners | Q4 2016 | Q1 2018 | $6.08 | $8.15 | +34% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.